XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Acquisition
9 Months Ended
Jun. 30, 2024
Business Combinations [Abstract]  
Acquisition Acquisition
Definitive Agreement to Acquire Edwards Lifesciences' Critical Care Product Group
On June 3, 2024, the Company announced that it had entered into a definitive agreement under which the Company will acquire Edwards Lifesciences' Critical Care product group (“Critical Care”), a global leader in advanced monitoring solutions, for $4.2 billion in cash. The acquisition will expand the Company’s portfolio of smart connected care solutions with Critical Care’s growing set of leading monitoring technologies, advanced AI-enabled clinical decision tools and robust innovation pipeline that complement the Company's existing technologies serving operating rooms and intensive care units.
The Company will fund the transaction with cash on hand, the net proceeds raised through debt issuances in the third quarter of fiscal year 2024, as further discussed in Note 14, and borrowings under our commercial paper program. The transaction is subject to customary regulatory reviews and closing conditions, and is expected to close by the end of calendar year 2024.